NCT06892327

Brief Summary

Obstetric ultrasound is the cornerstone of fetal growth assessment. It provides essential biometric measurements for estimating fetal weight, monitoring growth and identifying conditions such as intrauterine growth retardation (IUGR) or macrosomia. The accuracy of these measurements depends largely on the expertise of the operator. Experienced practitioners excel at positioning the probe, identifying anatomical landmarks and obtaining reproducible measurements. In contrast, novice operators, such as medical residents, may find it difficult to capture optimal images or identify precise landmarks, resulting in significant variability. This inter-observer variability, well documented even among experts, can have an impact on clinical decisions and obstetric management. For novices, variability is more pronounced, which can affect diagnostic reliability and patient care. Improving resident training is therefore essential to reduce this variability. Traditional solutions to minimizing variability, such as increased supervision, face limitations due to time constraints and resource availability. Recent advances in Artificial Intelligence (AI) could help in the training of residents. In obstetrics, AI could potentially automate biometric measurements by identifying key anatomical landmarks and performing precise, consistent measurements. These systems might standardize acquisition and reduce variability, making measurements less dependent on operator experience. AI technologies could significantly improve novice performance by potentially shortening the learning curve and enhancing measurement reliability. This might enable residents to work more independently while maintaining accuracy. Despite these potential advantages, few studies would have rigorously compared AI-assisted novice performance with that of expert practitioners under real-world conditions.This study aims to assess the possible effectiveness of AI in supporting novice operators during obstetric biometric measurements. The primary objective would be to determine whether AI assistance could enable novices to achieve measurement accuracy comparable to that of experienced practitioners, while potentially improving reproducibility and reducing inter-observer variability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 24, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

April 25, 2025

Status Verified

March 1, 2025

Enrollment Period

Same day

First QC Date

March 12, 2025

Last Update Submit

April 22, 2025

Conditions

Keywords

ultrasoundBiometric measurementsartificial intelligenceobstetrics

Outcome Measures

Primary Outcomes (1)

  • Accuracy of biometric measurements: Assessment of agreement between manual and AI-assisted measurements.

    The individual biometric measurements, such as biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), and femur length (FL), will be presented separately based on their respective units (cm). The estimated fetal weight, which will be based on the aggregation of these various measurements (BPD, HC, AC, FL), will be reported in kilograms (kg). This estimate will be calculated using fetal growth formulas adapted to these parameters. We will clarify that the fetal weight estimate will be calculated based on a model that incorporates these different measurements in the appropriate units. In summary, each measurement will be clearly separated based on its unit, and the fetal weight estimate will be explained to show how the different measurements are combined.

    36 weeks amenorrhea

Study Arms (1)

Routine Follow-Up: Patients scheduled for a standard biometric ultrasound.

Maternal Age: Pregnant women aged between 18 and 45 years. Pregnancy Type: Singleton viable pregnancy (excluding twin or multiple gestations). Gestational Age: Between 17 weeks and 38 weeks of gestation.

Other: standard biometric ultrasound

Interventions

In this study, biometric measurements were systematically performed for each patient using both manual methods and an artificial intelligence (AI) system (Live View Assist, Samsung). The AI system provided real-time guidance by identifying anatomical landmarks and assisting in the measurement of key biometric parameters, including Femur Length (FL), Abdominal Circumference (AC), Head Circumference (HC), and Biparietal Diameter (BPD). This dual approach ensured that both manual and AI-assisted methods were applied uniformly as part of routine clinical care.

Routine Follow-Up: Patients scheduled for a standard biometric ultrasound.

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant woman

You may qualify if:

  • Pregnant women aged between 18 and 40 years.
  • Singleton or twin ongoing pregnancies.
  • Gestational age between 20 and 36 weeks of amenorrhea (WA).
  • Patients scheduled for a biometric ultrasound (standard follow-up).

You may not qualify if:

  • Known major fetal anomalies that could affect biometric measurements.
  • Technical difficulties during the ultrasound (e.g., maternal obesity, complex abdominal scars).
  • History of severe maternal conditions affecting biometric measurements (e.g., uterine malformations)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospices Civils de Lyon, Maternité Croix Rousse

Lyon, 69004, France

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 12, 2025

First Posted

March 24, 2025

Study Start

April 1, 2025

Primary Completion

April 1, 2025

Study Completion

April 1, 2025

Last Updated

April 25, 2025

Record last verified: 2025-03

Locations